PL2643460T3 - Sposoby, kompozycje i zestawy do oznaczania ludzkiego wirusa niedoboru odporności (HIV) - Google Patents

Sposoby, kompozycje i zestawy do oznaczania ludzkiego wirusa niedoboru odporności (HIV)

Info

Publication number
PL2643460T3
PL2643460T3 PL12801310T PL12801310T PL2643460T3 PL 2643460 T3 PL2643460 T3 PL 2643460T3 PL 12801310 T PL12801310 T PL 12801310T PL 12801310 T PL12801310 T PL 12801310T PL 2643460 T3 PL2643460 T3 PL 2643460T3
Authority
PL
Poland
Prior art keywords
hiv
kits
compositions
methods
immunodeficiency virus
Prior art date
Application number
PL12801310T
Other languages
English (en)
Inventor
Danuta Wronska
Katherine Schouest
Leslie Tremlett
Original Assignee
Grifols Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Grifols Therapeutics Inc filed Critical Grifols Therapeutics Inc
Publication of PL2643460T3 publication Critical patent/PL2643460T3/pl

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G01N33/56988—HIV or HTLV
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C12Q1/702—Specific hybridization probes for retroviruses
    • C12Q1/703—Viruses associated with AIDS
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • AIDS & HIV (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
PL12801310T 2011-06-15 2012-06-14 Sposoby, kompozycje i zestawy do oznaczania ludzkiego wirusa niedoboru odporności (HIV) PL2643460T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161497234P 2011-06-15 2011-06-15
EP12801310.9A EP2643460B1 (en) 2011-06-15 2012-06-14 Methods, compositions, and kits for determining human immunodeficiency virus (hiv)
PCT/US2012/042365 WO2012174187A2 (en) 2011-06-15 2012-06-14 Methods, compositions, and kits for determining human immunodeficiency virus (hiv)

Publications (1)

Publication Number Publication Date
PL2643460T3 true PL2643460T3 (pl) 2018-01-31

Family

ID=47357719

Family Applications (1)

Application Number Title Priority Date Filing Date
PL12801310T PL2643460T3 (pl) 2011-06-15 2012-06-14 Sposoby, kompozycje i zestawy do oznaczania ludzkiego wirusa niedoboru odporności (HIV)

Country Status (14)

Country Link
US (1) US9273366B2 (pl)
EP (1) EP2643460B1 (pl)
CN (1) CN103635575B (pl)
AR (1) AR086925A1 (pl)
AU (1) AU2012271672B2 (pl)
BR (1) BR112013032223A2 (pl)
ES (1) ES2644839T3 (pl)
HU (1) HUE036963T2 (pl)
MX (1) MX340053B (pl)
PL (1) PL2643460T3 (pl)
PT (1) PT2643460T (pl)
RU (1) RU2584573C2 (pl)
UY (1) UY34128A (pl)
WO (1) WO2012174187A2 (pl)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10113206B2 (en) * 2010-02-24 2018-10-30 Grifols Therapeutics Inc. Methods, compositions, and kits for determining human immunodeficiency virus (HIV)
AP2017009731A0 (en) * 2014-07-24 2017-02-28 Abbott Molecular Inc Compositions and methods for the detection and analysis of mycobacterium tuberculosis
EP3322483A4 (en) 2015-07-14 2019-01-02 Abbott Molecular Inc. Compositions and methods for identifying drug resistant tuberculosis

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4458066A (en) 1980-02-29 1984-07-03 University Patents, Inc. Process for preparing polynucleotides
US4415732A (en) 1981-03-27 1983-11-15 University Patents, Inc. Phosphoramidite compounds and processes
US4605735A (en) 1983-02-14 1986-08-12 Wakunaga Seiyaku Kabushiki Kaisha Oligonucleotide derivatives
US4757141A (en) 1985-08-26 1988-07-12 Applied Biosystems, Incorporated Amino-derivatized phosphite and phosphate linking agents, phosphoramidite precursors, and useful conjugates thereof
US4826967A (en) 1987-06-16 1989-05-02 Naxcor Psoralen-nucleoside adducts and method for their preparation
US5082934A (en) 1989-04-05 1992-01-21 Naxcor Coumarin derivatives for use as nucleotide crosslinking reagents
CA2020958C (en) 1989-07-11 2005-01-11 Daniel L. Kacian Nucleic acid sequence amplification methods
US5847096A (en) * 1991-08-30 1998-12-08 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services DNA constructs encoding CD4 fusion proteins
US6965020B2 (en) 1996-01-23 2005-11-15 Affymetrix, Inc. Nucleic acid labeling compounds
CA2222769C (en) * 1997-01-17 2001-06-12 F. Hoffmann-La Roche Ag Primers for the detection of hiv-1
US6534273B2 (en) 1997-05-02 2003-03-18 Gen-Probe Incorporated Two-step hybridization and capture of a polynucleotide
HK1042706A1 (zh) * 1998-08-03 2002-08-23 东卡罗来纳大学 低腺苷反义寡核苷酸制剂、组合物、试剂盒及处理
ES2234563T5 (es) * 1999-02-12 2018-01-17 Daiichi Sankyo Company, Limited Nuevos análogos de nucleósidos y oligonucleótidos
US20030027135A1 (en) * 2001-03-02 2003-02-06 Ecker David J. Method for rapid detection and identification of bioagents
US20040121309A1 (en) 2002-12-06 2004-06-24 Ecker David J. Methods for rapid detection and identification of bioagents in blood, bodily fluids, and bodily tissues
JP2008512129A (ja) * 2004-09-10 2008-04-24 セクエノム，インコーポレイティド 核酸の広範囲配列分析法
WO2007073149A1 (en) 2005-12-22 2007-06-28 Keygene N.V. Alternative nucleotides for improved targeted nucleotide exchange
KR20080037128A (ko) 2006-10-25 2008-04-30 주식회사 씨젠 뉴클레오타이드 변이 검출 방법
US20110262924A1 (en) * 2008-12-19 2011-10-27 Abbott Laboratories Molecular assay for diagnosis of hiv tropism

Also Published As

Publication number Publication date
PT2643460T (pt) 2017-10-24
BR112013032223A2 (pt) 2016-12-20
CN103635575B (zh) 2019-03-01
WO2012174187A2 (en) 2012-12-20
AU2012271672A1 (en) 2013-05-02
EP2643460A4 (en) 2014-05-21
MX2013013293A (es) 2013-12-12
CN103635575A (zh) 2014-03-12
RU2584573C2 (ru) 2016-05-20
RU2013151821A (ru) 2015-05-27
US20140120526A1 (en) 2014-05-01
ES2644839T3 (es) 2017-11-30
HUE036963T2 (hu) 2018-08-28
US9273366B2 (en) 2016-03-01
UY34128A (es) 2013-01-31
WO2012174187A3 (en) 2013-03-28
EP2643460B1 (en) 2017-07-26
AR086925A1 (es) 2014-01-29
MX340053B (es) 2016-06-22
AU2012271672B2 (en) 2016-02-18
EP2643460A2 (en) 2013-10-02

Similar Documents

Publication Publication Date Title
AU2016202543A1 (en) Human immunodeficiency virus (hiv)-neutralizing antibodies
PT3556396T (pt) Anticorpos neutralizantes do vírus da imunodeficiência humana (vih)
EP2707025B8 (en) Hendra and nipah virus g glycoprotein immunogenic compositions
HUE053545T2 (hu) Humán immundeficiencia vírus semlegesítõ antitestek és eljárások alkalmazásukra
GB201115214D0 (en) Influenza virus antibody compositions
EP2764102A4 (en) METHOD AND COMPOSITIONS FOR REGULATING HIV INFECTIONS
PT3260136T (pt) Anticorpos de neutralização do vírus da imunodeficiência humana (hiv)
EP2670419A1 (en) Psa capture agents, compositions, methods and preparation thereof
ZA201307529B (en) Truncated hiv envelope proteins (env), methods and compositions related thereto
IL231132A0 (en) Viral cleaning methods
EP2763998A4 (en) TRI-HETEROCYCLIC DERIVATIVES, MANUFACTURING METHOD AND USES THEREOF
IL228006B (en) Endodontic instruments, kits and methods for using endodontic instruments
EP2852662A4 (en) HERPESVIRUS COMPOSITIONS AND RELATED METHODS
IL228085A0 (en) Preparations and methods for the separation, characterization and administration of soluble selenoglycoproteins
WO2013052095A3 (en) Vaccine
EP2766183A4 (en) IRON FIBER COMPOSITION, PREPARATION THEREOF AND USES THEREOF
IL231494A0 (en) Lentiviral genome without chimeric integration as components against hiv-1
PL2643460T3 (pl) Sposoby, kompozycje i zestawy do oznaczania ludzkiego wirusa niedoboru odporności (HIV)
WO2012139097A3 (en) Method of inducing neutralizing antibodies to human immunodeficiency virus
ZA201307019B (en) Compositions for preventing and/or treating and infection by an hiv-1 virus
PT2643461T (pt) Métodos, composições e kits para determinação do vírus da hepatite a
BR112014014825A8 (pt) composições naturais, de liberação múltipla e de reutilização
SG11201402899TA (en) Methods and compositions for treating viral diseases
AU2013369626A1 (en) Dengue virus vaccine composition
AU2012905097A0 (en) Agents and methods for inhibiting virus infection